{"cik":"0001603345","ticker":"AGTX","name":"Agentix Corp.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"OTC","state_of_incorporation":"NV","fiscal_year_end":"0331","first_filing_date":"2026-07-01","last_filing_date":"2026-07-01","url":"/sec/cik-0001603345","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001477932-26-004781","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-10","title":"10-Q — Agentix Corp. — 2026-08-10","url_slug":"/sec/cik-0001603345/10-q/0001477932-26-004781","edgar_url":"https://www.sec.gov/Archives/edgar/data/1603345/0001477932-26-004781-index.html"},{"accession_number":"0001477932-26-004133","form_type":"10-K","form_type_family":"annual","doc_date":"2026-07-01","title":"10-K — Agentix Corp. — 2026-07-01","url_slug":"/sec/cik-0001603345/10-k/0001477932-26-004133","edgar_url":"https://www.sec.gov/Archives/edgar/data/1603345/0001477932-26-004133-index.html"}],"related_endpoints":{"profile":"/sec/AGTX/profile","timeline":"/sec/AGTX/timeline","peers":"/sec/AGTX/peers","insider_pulse":"/sec/AGTX/insider-pulse","insider_summary":"/sec/AGTX/insider-summary","insider_transactions":"/sec/AGTX/insider-transactions","form144":"/sec/AGTX/form144","holdings_as_filer":"/sec/AGTX/holdings","financial_facts":"/sec/AGTX/financial-facts","derivatives":"/sec/AGTX/derivatives","officers":"/sec/AGTX/officers","insider_network":"/sec/AGTX/insider-network","risk_flags":"/sec/AGTX/risk-flags","filings":"/sec/AGTX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=AGTX"}}